Scientific Review Committee
Each of our Research Scholars Programs is overseen by a scientific review committee composed of distinguished experts in their respective fields who are independent from Gilead to ensure equal, objective evaluation of all applicants and their applications. This enables us to maintain the program’s overall integrity and competitive standards, and to ensure awards support the next generation of breakthrough scientific discovery.
Chair
Sara M. Tolaney, MD, MPH
Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women's Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine Harvard Medical School
Review Committee
Adam Brufsky, MD, PhD
Professor of Medicine, University of Pittsburgh
Co-Director Comprehensive Breast Cancer Program
Mary Jo Fidler, MD
Medical Oncology Section Chief Professor
Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy
Jhanelle Gray, MD
Professor, University of South Florida, Morsani College of Medicine
Department Chair
Petros Grivas, MD, PhD
Professor, University of Washington, Fred Hutchinson Cancer Center
Clinical Director of GU Cancers Program
Jaffer A. Ajani, MD
Professor of Medicine, Department of Gastrointestinal Medical Oncology
University of Texas
Gregory Cote, MD, PhD
Assistant Professor of Medicine, Center for Sarcoma and Connective Tissue Oncology
Mass General Hospital Cancer Center
Harvard Medical School
Bora Lim, MD
Associate Professor of Medicine, Breast Medical Oncology
University of Texas
Komal Jhaveri, MD
Associate Professor of Medicine, Weill Cornell Medical College
Associate Attending Physician
Taofeek K. Owonikoko, MD, PhD, MS
Professor of Medicine, Oncology
University of Maryland School of Medicine
